Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

HKT-500 in Adult Patients With Shoulder Pain

ClinicalTrials.gov ID: NCT00680472

Public ClinicalTrials.gov record NCT00680472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Protocol HKT-500-US08: A Randomized, Multicenter, Double-blind, Placebo-controlled, Two-week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Acute Shoulder Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to determine the efficacy of HKT-500 in subjects with acute shoulder pain

Study identification

NCT ID
NCT00680472
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
368 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Oct 2008 (Actual)
Completion
Oct 2008 (Actual)
Last update posted
Jun 4, 2015

2008

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Hisamitsu Investigator Site Birmingham Alabama 35209 —
Hisamitsu Investigator Site Tempe Arizona 85283 —
Hisamitsu Investigator Site Fullerton California 92835 —
Hisamitsu Investigator Site Denver Colorado 80204 —
Hisamitsu Investigator Site Washington D.C. District of Columbia 20003 —
Hisamitsu Investigator Site Bradenton Florida 34209 —
Hisamitsu Investigator Site Chiefland Florida 32626 —
Hisamitsu Investigator Site DeLand Florida 32720 —
Hisamitsu Investigator Site Delray Beach Florida 33484 —
Hisamitsu Investigator Site Dunedin Florida 34698 —
Hisamitsu Investigator Site Longwood Florida 32779 —
Hisamitsu Investigator Site Oldsmar Florida 34677 —
Hisamitsu Pharmaceutical Co., Inc. Orange City Florida 32763 —
Hisamitsu Investigator Site Plantation Florida 33324 —
Hisamitsu Investigator Site Tampa Florida 33603 —
Hisamitsu Investigator Site Tampa Florida 33609 —
Hisamitsu Investigator Site Blue Ridge Georgia 30513 —
Hisamitsu Investigator Site Boise Idaho 83702 —
Hisamitsu Investigator Site Wichita Kansas 67205 —
Hisamitsu Investigator Site Paducah Kentucky 42003 —
Hisamitsu Investigator Site Bowie Maryland 20716 —
Hisamitsu Investigator Site Kalamazoo Michigan 49009 —
Hisamitsu Investigator Site Bridgewater New Jersey 08807 —
Hisamitsu Investigator Site Cary North Carolina 27513 —
HIsamitsu Pharmaceutical Co., Inc. Durham North Carolina 27704 —
Hisamitsu Investigator Site Raleigh North Carolina 27615 —
Hisamitsu Investigator Site Fargo North Dakota 58104 —
Hisamitsu Investigator Site Fargo North Dakota 58108 —
HIsamitsu Pharmaceutical Co., Inc. Perrysburg Ohio 43551 —
Hisamitsu Investigator Site Toledo Ohio 43623 —
Hisamitsu Investigator Site Zanesville Ohio 43701 —
Hisamitsu Investigator Site New Tazewell Tennessee 37825 —
Hisamitsu Investigator Site Bryan Texas 77802 —
Hisamitsu Investigator Site San Antonio Texas 78217 —
Hisamitsu Investigator Site Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00680472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2015 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00680472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →